Filing Details
- Accession Number:
- 0000950170-24-061294
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-16 19:37:39
- Reporting Period:
- 2024-05-14
- Accepted Time:
- 2024-05-16 19:37:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658551 | Amylyx Pharmaceuticals Inc. | AMLX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543031 | Daphne Quimi | C/O Amylyx Pharmaceuticals, Inc. 43 Thorndike Street Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-14 | 2,750 | $1.89 | 2,750 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-05-15 | 2,250 | $1.89 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
